HK Stock MarketDetailed Quotes

01177 SINO BIOPHARM

Watchlist
  • 2.910
  • +0.100+3.56%
Market Closed Jan 17 16:08 CST
54.68BMarket Cap12.18P/E (TTM)

SINO BIOPHARM Key Stats

SINO BIOPHARM Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 31, 20222021/Q46.254B / 6.192B--
--2021/Q36.254B / 6.448B--
Aug 31, 20212021/Q27.111B / 7.370B--
May 24, 20212021/Q17.243B / 6.399B--
Mar 23, 20212020/Q45.521B / 6.237B--
DatePeriodRevenue/EstimateEarnings Call
Mar 31, 20222021/Q46.254B / 6.192B--
--2021/Q36.254B / 6.448B--
Aug 31, 20212021/Q27.111B / 7.370B--
May 24, 20212021/Q17.243B / 6.399B--
Mar 23, 20212020/Q45.521B / 6.237B--

Unlock Free Earnings Estimates

SINO BIOPHARM Earnings Reports

Read more

Trending HK Stocks
HK Crypto ETF HK Crypto ETF

An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data. An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 18, 2025

Strong Buy

  • Strong Buy

    93.75%
  • Buy

    6.25%
  • Hold

    0.00%
  • Underperform

    0.00%
  • Sell

    0.00%

Price Target

No Data